Destiny Wealth Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-475
Closed -$28.2K 821
2026
Q1
$28.2K Buy
+475
New +$30.8K ﹤0.01% 577
2023
Q1
Sell
-5,234
Closed -$328K 492
2022
Q4
$328K Sell
5,234
-220
-4% -$12.6K 0.07% 131
2022
Q3
$272K Buy
5,454
+1,566
+40% +$86.7K 0.06% 149
2022
Q2
$229K Buy
+3,888
New +$214K 0.05% 148

Other funds holding PBH

Destiny Wealth Partners's PBH Position: Q2 2026 in Review

Destiny Wealth Partners sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 475 shares — an estimated $28.2K sold.

Destiny Wealth Partners first reported a position in PBH in Q2 2022 and held it in 4 quarters. The position peaked at $328K in Q4 2022. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Destiny Wealth Partners reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Destiny Wealth Partners sold 475 Prestige Consumer Healthcare shares in Q2 2026, an estimated $28.2K.
  • Destiny Wealth Partners first reported a position in Prestige Consumer Healthcare in Q2 2022 and held it in 4 quarters.
  • Destiny Wealth Partners's Prestige Consumer Healthcare position peaked at $328K in Q4 2022.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.